RESEARCH DOSSIER
Maintenance of Therapeutic Gains and Relapse Prevention
Abstract. Maintenance of therapeutic gains is the preservation, generalization, and ongoing application of improvements obtained through psychological treatment after the intensive therapeutic phase. This fundamental research monograph examines how posttreatment competencies are consolidated and transferred, how symptom return and recurrence are defined, and which preventive interventions have been evaluated experimentally. Its evidence base brings together original continuation cognitive-therapy trials, preventive cognitive therapy and mindfulness-based relapse-prevention research, exposure and response prevention, family and psychoeducation approaches, substance-use aftercare, longitudinal outcome studies, and methodological evidence syntheses. It distinguishes spontaneous stability from an experimentally demonstrated preventive effect, and the recurrence of diagnosed symptoms from lapses in independent therapeutic skills. Critical analysis addresses responder selection, remaining symptoms, heterogeneous relapse definitions, causal attribution, treatment discontinuation, competing care, social determinants, adverse experiences, and incomplete follow-up. The synthesis concludes that durable therapeutic change is a time- and context-dependent outcome requiring disorder-specific measurement, individualized transitions, independent skill use, and accessible support. Future research should test the components, timing, burden, and clinical effectiveness of maintenance strategies using sufficiently long randomized and pragmatic follow-up. The method is a critical narrative synthesis of identified scientific sources, rather than a preregistered systematic review, new meta-analysis, or original clinical trial.
Keywords: maintenance of therapeutic gains; psychotherapy durability; relapse prevention; recurrence; continuation cognitive therapy; preventive cognitive therapy; mindfulness-based cognitive therapy; booster sessions; exposure and response prevention; skill generalization; relapse planning; recurrent depression; anxiety; obsessive-compulsive disorder; psychiatric aftercare; longitudinal treatment outcomes; preventive interventions; implementation science.
The Scientific Object of Therapeutic Maintenance
Maintenance of therapeutic gains is the preservation, adaptation, and practical use of improvements achieved during psychological treatment after the intensive phase has ended. These gains may include reduced distress, greater behavioral flexibility, strengthened regulation skills, improved relationships, restored participation, and a changed capacity to respond to future stress. Relapse prevention comprises interventions intended to reduce the probability, severity, duration, or consequences of subsequent clinical deterioration. Their common research object is the durability of treatment-generated change under circumstances that differ from those in which the change was acquired. This object requires observation of what people actually do, experience, and sustain between therapeutic contacts, not merely their scores at the last session.
This monograph examines maintenance strategies attached to psychotherapy: continuation treatment, planned follow-up, preventive cognitive therapy, mindfulness practice, exposure generalization, skills rehearsal, relapse-response planning, family involvement, and appropriate reentry into care. It distinguishes initial symptom improvement from enduring competence and distinguishes an intervention's short-term success from its preventive effect in a randomized follow-up comparison. The scientific emphasis falls on what therapeutic learning survives when the therapist, structured setting, and immediate reinforcement recede. Diagnosis-specific disease course and pharmacological maintenance are important comparators, but their full treatment belongs to neighboring research domains.
The method is a critical narrative synthesis of identifiable randomized trials, longitudinal studies, mechanistic investigations, meta-analyses, and current clinical guidelines. Evidence is organized by research question and design; individual figures are attributed to the specific samples that produced them. This is neither a preregistered systematic review nor an original meta-analysis. Its conclusions describe the strongest supported patterns and the important limits of inference rather than declaring a universal relapse-prevention program.
Defining Response, Remission, Recovery, Relapse, and Recurrence
A therapeutic gain must be specified before its durability can be evaluated. Response ordinarily denotes meaningful improvement relative to baseline, whereas remission describes symptoms below a specified threshold. Functional improvement refers to changes in daily activity, education, work, relationships, or valued participation. Maintenance refers to the retention of a defined gain over a stated interval; it can occur even when residual symptoms remain. Relapse and recurrence have more technical meanings in some literatures, especially depression, where relapse conventionally refers to symptom return before a sustained recovery interval and recurrence to a subsequent episode after recovery. Frank (1991) proposed consistency in these change-point definitions.
For psychotherapy research, a lapse can denote a brief departure from a learned behavioral pattern, while a relapse usually implies a more substantial or sustained return of the target problem. The same lapse may have different meanings for compulsive rituals, substance use, avoidance, self-injury, and recurrent depression. Investigators therefore need explicit event definitions, measurement frequencies, observation windows, and clinical thresholds. A reduction in scale scores over six months and a reduction in the probability of a new diagnostic episode are different effects. So are retained gains among all treatment starters and retained gains among those who initially responded.
Outcomes become more interpretable when studies report both continuous trajectories and clinically meaningful events, and when they state whether outcomes were assessed through independent interviews, patient self-report, digital records, or routine services. The definitions of illness transitions in Frank (1991) remain a reference point for depression research, but their duration thresholds should not be projected mechanically onto other conditions. A scientifically useful maintenance framework keeps the outcome tied to the problem treated and the person's functional goals.
Historical Foundations of Relapse Prevention in Psychotherapy
The modern research program emerged from several connected traditions. Behavioral treatment established that newly acquired behavior required maintenance and transfer beyond the treatment setting. Cognitive therapy proposed that learning to identify and modify dysfunctional interpretations might remain useful after sessions ended. Alcohol and other substance-use treatment developed explicit approaches to high-risk situations, coping, and the consequences of an initial lapse. Longitudinal psychiatric research subsequently emphasized standard definitions of remission and recurrence, allowing treatment effects to be assessed beyond an immediate posttreatment endpoint.
Clinical experiments gradually made these ideas falsifiable. In obsessive-compulsive disorder, Hiss (1994) tested a relapse-prevention component following intensive exposure and response prevention in a small sample. Gortner (1998) examined two-year outcomes following different components of cognitive-behavioral treatment for depression. Jarrett (2001) randomized higher-risk cognitive-therapy responders to continuation-phase cognitive therapy or assessment control. These studies shifted the central question from whether patients improved during treatment to whether strategically delivered therapeutic learning helped keep them well.
Later programs introduced preventive cognitive therapy after remission, mindfulness-based cognitive therapy for recurrent depression, structured psychoeducation for bipolar disorders, and mindfulness-based relapse prevention after addiction treatment. Meta-analytic research provided broader but necessarily heterogeneous comparisons. The history documents a transition from anecdotal claims of lasting benefit toward event-based trials, long follow-up, mediator analysis, and attention to treatment selection. It also shows why the historical popularity of a maintenance technique should be distinguished from direct experimental confirmation of its particular causal mechanism.
A Model of Therapeutic Learning and Its Durability
Psychotherapy can generate several kinds of change: acquisition of a new skill, revision of a predictive belief, exposure to previously avoided situations, improved ability to detect emerging problems, stronger interpersonal responses, or more reliable access to supportive environments. Such changes have different maintenance requirements. A practiced behavioral response may persist through repetition and reinforcement. A corrective expectation may remain context-sensitive and require retrieval under new circumstances. An interpersonal gain may depend upon whether the person's social environment allows newly practiced behavior to continue.
One useful analytic distinction is acquisition, consolidation, generalization, and recovery after setback. Acquisition concerns initial performance during intervention. Consolidation concerns whether the skill or learning becomes stable across time and interference. Generalization tests performance in unfamiliar settings, relationships, affective states, and demands. Recovery after setback is the capacity to reengage effective strategies when distress or symptoms reappear. A therapeutic skill that works only with therapist prompts has a different status from one the patient can deploy independently during a stressful week.
The exposure-learning synthesis of Craske (2014) illustrates how durability can depend on retrieval conditions rather than simple erasure of prior threat learning. Conversely, the cognitive-therapy study of Strunk (2007) found that independent use of learned skills predicted subsequent relapse risk in a small sample of depression responders. These findings suggest testable mechanisms; they do not imply that skill use alone explains all long-term outcomes. Treatment effects unfold within biological vulnerability, social resources, exposure to stress, and access to renewed care.
The Transition From Active Therapy to Independent Practice
The final phase of psychotherapy creates a distinctive change in the system supporting improvement. Scheduled meetings, collaborative observation, accountability, rehearsal opportunities, and therapist feedback become less frequent or disappear. Maintenance therefore concerns the patient's capacity to organize effective action without the same immediate scaffolding. A treatment can produce substantial symptom relief while leaving some strategies dependent on contextual cues available only in sessions. Termination planning is a deliberate effort to transfer responsibility, resources, and decision procedures into everyday life.
The transition is best understood as a clinical and methodological phase rather than a ceremonial ending. A maintenance assessment can document which gains are robust, which remain fragile, and what circumstances tend to interrupt them. It should distinguish a negotiated completion of adequate treatment from an unplanned discontinuation caused by cost, dissatisfaction, scheduling, access barriers, or adverse experience. The latter introduces selection and safety concerns into any attempt to interpret outcomes among those who finished therapy.
The depression guideline National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations (2022) explicitly includes reviewing lessons learned, identifying warning signs, planning maintenance activities, and anticipating difficult events in its relapse-prevention recommendations. This institutional guidance supports a structured transition but is not proof that every individual planning element independently prevents recurrence. Research must still determine which components, doses, and follow-up intervals are beneficial for different populations. The clinical value of a plan depends on its feasibility, acceptability, and ability to be revised as life circumstances change.
Skill Acquisition, Competence, and Independent Use
A central hypothesis of cognitive-behavioral maintenance is that patients acquire procedures they can apply after formal treatment ends. These include identifying warning signs, testing interpretations, scheduling rewarding activity, approaching avoided situations, managing problem-solving demands, and asking for support. The crucial distinction is between recognizing a technique during a session and selecting it independently when distress is high. Procedural availability may be more predictive of enduring change than declarative familiarity with therapeutic vocabulary.
Strunk (2007) examined 35 patients who had responded to cognitive therapy for moderate-to-severe depression. Greater competence in cognitive-therapy skills and more independent implementation during sessions predicted lower relapse risk over the following year, beyond end-of-treatment symptom severity and symptom change in the reported analyses. The sample was small, and prediction within responders is not evidence that experimentally increasing a specific skill necessarily causes fewer relapses. Nonetheless, the study identifies a concrete candidate mechanism and a way to measure it.
Future research should separate actual use, demonstrated competence, self-reported frequency, confidence in a skill, and conditions enabling its performance. Behavioral tasks, ecological assessments, and independent ratings could reveal when an apparently mastered skill fails under fatigue, social threat, or conflicting demands. Maintenance programs should be evaluated for whether they produce autonomous use rather than only attendance, workbook completion, or short-term satisfaction. The skill hypothesis becomes scientifically informative when its proposed mediator changes before the later clinical outcome and when alternative explanations are assessed.
Generalization Across Everyday Settings and Stressors
Improvements achieved in therapy must operate in a changing environment. A patient may practice alternative behavior in an office but face different emotional cues, family responses, work demands, or economic restrictions outside that setting. Generalization is the observed transfer of learning across people, places, tasks, and states. It is a substantive outcome of therapy, not a decorative addition to final-session planning. For people whose target problems are strongly tied to particular cues, maintenance requires examining which cues remain untested.
Behavioral traditions emphasize varied practice and access to natural reinforcement. Cognitive treatment adds flexible interpretation and problem solving in situations that differ from rehearsed examples. Exposure therapy shows the importance of context through fear renewal: a fear response can return in a setting where the corrective learning was less readily retrieved. Wang (2024), reviewing human fear-conditioning studies, found that the magnitude of renewal depended on experimental context arrangements. This provides mechanistic support for examining context diversity, while laboratory conditioning outcomes should not be equated automatically with clinical relapse.
Generalization may also depend on structural features beyond personal control. A person who learns effective coping but returns to ongoing violence, inaccessible care, severe financial insecurity, or unstable housing faces constraints that skills practice alone cannot remove. Maintenance research must therefore include environmental opportunity and constraints as potential moderators rather than treating every deterioration as an internal failure of motivation. A comprehensive intervention can combine patient skills with appropriate social, family, community, and service resources without claiming that any one component always suffices.
Lapses, Setbacks, and the Meaning of Symptom Return
A setback is best measured as an event in a trajectory, with its duration, intensity, functional consequences, and response recorded. Brief anxiety during a feared situation can occur within successful exposure-based change. A missed activity after a period of improvement does not establish depressive recurrence. An isolated return of a compulsion may require renewed response prevention, but the clinical significance depends upon its persistence and impact. In addiction research, a return to substance use carries its own definitions, biological risks, and service requirements; the interpretation of a lapse must remain condition-specific.
The research question concerns what happens after a lapse: whether avoidance increases, coping repertoire narrows, distress escalates, or effective action resumes. Relapse-prevention plans may attempt to interrupt sequences in which a transient difficulty produces discouragement, reduced self-efficacy, and further disengagement. These sequences constitute plausible hypotheses that require longitudinal and experimental examination. It is misleading to interpret a single symptomatic day as either complete treatment failure or guaranteed future recurrence.
The small obsessive-compulsive disorder experiment of Hiss (1994) and the later maintenance report by McKay (1997) illustrate early attempts to formalize ways of responding to setbacks after exposure and response prevention. Their sample and design limitations constrain generalization. A defensible modern maintenance study should report the course and consequences of symptom returns, not just a single binary event, and should investigate whether flexible early responses change those courses.
Residual Symptoms and Remaining Vulnerability
End-of-treatment symptom reduction can coexist with substantial vulnerability. Residual low mood, worry, sleep disruption, avoidance, intrusive experiences, or impaired functioning may make future deterioration more likely, yet residual symptoms also differ in cause and prognostic meaning. Persistent difficulties can reflect incomplete treatment response, ongoing environmental stress, comorbidity, or a condition with a naturally fluctuating course. They therefore warrant direct measurement before a preventive intervention is assigned the task of preserving an improvement that may never have reached the intended threshold.
In major depression, Judd (1998) described the association between residual subthreshold symptoms and rapid relapse in prospective observational research. More recently, Gülpen (2025) synthesized individual participant data from randomized trials involving people in partial remission. Psychological interventions were associated with lower relapse risk over 12 months in that defined population, while improvements in quality of life were less clear. These findings make residual symptom burden a clinically and experimentally relevant target without establishing a single universal threshold at which additional therapy becomes necessary.
Maintenance trials also need to distinguish preventive effects from additional acute treatment of residual illness. If an intervention substantially reduces persisting symptoms after randomization, some of its apparent protection may derive from improving initial remission rather than stabilizing already achieved gains. This possibility can be addressed through symptom-trajectory analysis, prespecified episode definitions, and careful choice of trial populations. It remains important to preserve separate outcomes for symptoms, functioning, and subjective well-being.
Measuring the Durability of Therapeutic Outcomes
Maintenance is a time-dependent property. A trial reporting change at the final session and one reporting three years of repeated follow-up assess different phenomena. Appropriate measurement combines baseline, end-of-treatment, and multiple posttreatment observations, with clearly identified dates and exposure to new treatment. For recurrent disorders, time to first relapse, cumulative event incidence, recurrent-event counts, symptom-free weeks, and functional trajectories provide complementary information. They should be selected in advance for the particular research question.
Psychometric instruments measure different constructs and can be sensitive to changes in reporting context. A standardized symptom scale may detect subthreshold deterioration, whereas a structured diagnostic interview determines whether operational episode criteria have been met. Patient-reported quality of life and participation capture outcomes important to the person even when symptom scores change little. Where behavior is central, ecological observations, adherence indicators, and context-specific performance tasks can inform maintenance. Each instrument requires evaluation of reliability, measurement invariance, responsiveness, and the practical meaning of score change.
Analyses must account for missing follow-up assessments. Participants with deteriorating symptoms may be harder to contact, while people who feel well may stop attending assessments. Complete-case analysis may misrepresent the course in either direction. Research reports should disclose how attrition, competing treatments, unblinded assessments, repeated outcome measurements, and postrandomization selection were handled. Maintenance claims are only as credible as the measurement schedule and the integrity of long-term observation.
Research Designs and the Identification of Preventive Effects
A randomized maintenance trial generally begins by selecting participants who have improved or reached a specified remission threshold. It then compares strategies such as continuation psychotherapy, a structured preventive course, medication continuation, usual care, monitoring, or a specific active control. Randomization improves causal identification of the assigned strategy within that selected population. It does not remove all interpretive problems: participants and therapists are rarely blinded, treatment preferences may influence adherence, and early deterioration may prompt new interventions that alter later observed outcomes.
Responder-enriched trials answer a narrower question than trials randomizing all people at treatment entry. They estimate the effect of a postresponse strategy among people who survived or responded to the preceding phase. A follow-up cohort without a randomized comparator can document stability but generally cannot establish that the earlier treatment caused the stable outcome. In analyses of time to recurrence, censoring assumptions, proportional hazards, and the handling of repeated events determine whether estimated effects have an interpretable meaning.
The original Hollon (2005) compared untreated cognitive-therapy responders with medication responders assigned to continuation medication or placebo withdrawal after acute treatment, then followed them further. The experiment contributed to discussion of enduring cognitive-therapy effects, but differences in the pathways leading to responder selection and the medication withdrawal conditions require attention. A maintenance synthesis should evaluate the counterfactual actually identified by each trial, the duration of observation, adverse experiences, and the relevance to contemporary treatment practice.
Enduring Effects of Acute Cognitive Therapy for Depression
The notion of an enduring effect proposes that successful psychotherapy may leave competencies or changes that continue after formal treatment stops. This is an empirical proposition about a treatment's posttreatment trajectory and comparator. It can be investigated by tracking patients who received acute cognitive therapy, behavioral activation, or medication and by recording subsequent interventions and relapse. A favorable follow-up outcome does not alone establish which specific cognitive, behavioral, interpersonal, or contextual process produced durability.
Gortner (1998) followed participants randomized to complete cognitive therapy or two component-based treatments and reported no greater relapse-prevention effect of the complete treatment over its components. This finding cautions against assuming that every component of a multi-element therapeutic package is necessary for maintenance. Hollon (2005) offered a different comparison of postresponse continuation strategies. Their findings are often cited as evidence that the benefit of cognitive therapy can persist after sessions finish, but that inference remains linked to the randomized designs and populations studied.
A comparative meta-analysis by Vittengl (2007) assembled research on relapse and recurrence after cognitive-behavioral interventions for depression. Such synthesis extends beyond individual trials but combines designs with different comparators, definitions, and follow-up durations. The resulting evidence supports continued investigation of durability and highlights why a maintenance effect must be stated with its exact comparison, not as a timeless characteristic of a named therapy.
Continuation-Phase Cognitive Therapy After Initial Response
Continuation-phase cognitive therapy is a structured period of treatment after response to acute cognitive therapy, designed to strengthen preventive skills and address persisting vulnerabilities. Sessions may be spaced over months and focus on situations associated with renewed depression, coping failures, lingering symptoms, and generalization of therapeutic learning. Its conceptual importance is that maintenance is tested as an intervention in its own right rather than treated as an automatic residue of the acute phase.
In the randomized study of Jarrett (2001), 84 unmedicated responders from an acute-phase cognitive therapy program were assigned to eight months of continuation cognitive therapy or assessment without continuing therapy. The PubMed abstract reports lower estimated relapse in the continuation condition during those eight months, 10% versus 31%. These figures pertain to a selected higher-risk sample and a defined interval; they should not be generalized to all people who complete therapy. The investigators also continued observation after the active continuation phase, making the distinction between benefits during added treatment and effects after its cessation explicit.
A later randomized trial by Jarrett (2013) compared continuation cognitive therapy, fluoxetine, and pill placebo among higher-risk responders. This design supplies a stronger test of relative prophylactic strategies while introducing its own issues of blinding, medication exposure, and posttreatment durability. Across studies, continuation-phase treatment is a testable dose-and-timing intervention. Its value depends on patient risk, the initial treatment response, comparative availability, burden, and meaningful long-term endpoints.
Preventive Cognitive Therapy After Remission
Preventive cognitive therapy differs conceptually from simply extending the final sessions of acute treatment. It can be offered to people who have remitted through different routes and is designed to reduce vulnerability to another depressive episode. Typical components include identifying patterns associated with recurrence, practicing new responses, and examining beliefs that become activated during low mood. Because treatment begins after remission, trials can ask whether preventive learning contributes beyond routine care or concurrent pharmacotherapy.
Bockting (2005) randomized 187 participants with recurrent depression to usual treatment or usual treatment augmented by brief group cognitive therapy and assessed relapse or recurrence over two years. In the subgroup with at least five prior episodes, reported cumulative rates were 72% in usual care and 46% in the augmented condition. That subgroup pattern should be interpreted in its prespecified or exploratory context and alongside the study's broader population; it establishes neither a universal threshold of five episodes nor the identical benefit in lower-risk populations.
Subsequent follow-up studies extended the observation period. Bockting and colleagues (2009) reported protective effects at 5.5 years in a recurrent-depression sample, with greater effects among participants with multiple prior episodes. Long follow-up is scientifically valuable, but the intervention, selection criteria, accumulating external treatments, and interval-specific risks must still be documented. Preventive cognitive therapy illustrates the possibility of targeted maintenance for a defined high-risk population, while leaving open how much preventive treatment and reinforcement are required over a lifetime.
Mindfulness-Based Cognitive Therapy and Recurrent Depression
Mindfulness-based cognitive therapy integrates structured attention practice with cognitive understanding of mood-related patterns. In relapse prevention, the proposed mechanism is an altered response to early negative affect and repetitive thinking, especially when low mood activates previously familiar depressive interpretations. The intervention trains recognition of changing mental events and flexible responding rather than attempting to guarantee the absence of difficult emotion. These theoretical pathways are susceptible to empirical mediation tests, although mindfulness is a multidimensional construct measured imperfectly by self-report.
The original randomized trial of Teasdale (2000) enrolled 145 previously depressed participants and examined MBCT as an addition to usual treatment. Later evidence developed through multiple trials and pooled individual participant data. The Kuyken (2016) evaluated the prevention of depressive relapse across randomized studies, providing a more reliable comparative context than any one trial. Variation in prior episode history, baseline symptoms, treatment as usual, instructor competence, and participant engagement remains important in interpreting preventive effectiveness.
The PREVENT randomized study by Kuyken (2015) compared MBCT with support for tapering or discontinuing antidepressants against maintenance antidepressants across a 24-month follow-up. Its design shows that MBCT may be considered within a shared decision over longitudinal care, but an intervention should not be described as superior simply because it offers a psychological alternative. Evidence must be read in terms of the trial's actual primary comparison, treatment adherence, harms, preferences, and uncertainty. These considerations apply whenever psychotherapy is examined alongside pharmacological strategies.
Sequential Psychotherapy and the Problem of Medication Discontinuation
Some maintenance research tests a psychological intervention while an antidepressant is being continued, tapered, or withdrawn. This is a scientifically demanding design because the comparison includes both psychotherapy exposure and medication change. Early symptoms following tapering may reflect relapse, withdrawal, medication-related adaptation, or combinations of processes. Study protocols vary in tapering schedules, monitoring, patient preferences, and exposure histories, making unqualified cross-trial claims hazardous.
The three-arm DRD randomized trial by Bockting (2018) compared preventive cognitive therapy plus continued antidepressants, antidepressants alone, and preventive cognitive therapy accompanied by antidepressant tapering in recurrently depressed adults who were in remission or recovery. Breedvelt (2021) later pooled individual data from randomized comparisons of sequential psychological interventions and antidepressant continuation. The reported 15-month hazard ratio of 0.86, with a 95% confidence interval of 0.60–1.23, did not demonstrate a clear difference between the compared strategies. That result should be interpreted as the evidence available for those specific regimens, not an equivalence trial establishing identical effects.
A scientifically sound monograph therefore treats medication continuation and deprescribing as topics requiring their own clinical decision rules and specialist guidance. Psychotherapy trials inform the probability of retaining gains under particular circumstances; they do not authorize individualized medication changes, dose schedules, or replacement claims. The current National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations (2022) addresses relapse prevention through shared treatment choice and attention to prior episodes, residual symptoms, coping styles, and contextual adversity.
Partially Remitted Depression and Preventive Psychotherapy
Prevention becomes conceptually complex when a person has improved substantially but continues to experience symptoms. In such populations, a new psychological intervention may be both continuation of active treatment and prevention of future deterioration. Trials that group partial remission with complete remission can obscure whether observed differences reflect greater improvement in residual illness, prevention of a newly defined episode, or both. Research on this population should therefore report baseline symptom severity, previous episode history, postintervention symptoms, and prospectively assessed new episodes.
The individual participant data synthesis by Gülpen (2025) included 16 randomized trials and 705 partial remitters. Across the defined comparisons, preventive psychological interventions were associated with lower twelve-month relapse risk, with a reported hazard ratio of 0.60 and a 95% confidence interval of 0.43–0.84. Quality-of-life outcomes at sixty weeks were not clearly improved. The report also identified baseline clinician-rated symptoms and prior depressive episodes as prognostic indicators. These estimates are specific to the synthesized partial-remission population and should not be carried over to anxiety, obsessive-compulsive disorder, or substance-use treatment.
The practical scientific implication is that remaining symptoms deserve their own outcome tracking rather than being treated as an inconvenient footnote to a success story. Whether a person needs further symptom-focused treatment, a preventive course, routine follow-up, or social support requires a condition-specific assessment. At the evidence level, future trials should separate preventing recurrence from achieving fuller remission and test whether baseline characteristics prospectively modify the benefit of different strategies.
Anxiety Disorders and Enduring Psychotherapy Gains
Anxiety treatment creates particular maintenance challenges because avoidance can return under stress, feared contexts may change, and patients may become less willing to practice exposure when immediate suffering has receded. Durability should therefore be assessed through both self-reported anxiety and behavioral engagement with previously avoided activities. A stable symptom score may conceal a return to restricted routines, whereas intermittent fear may coexist with robust improvement in functioning. Measures of avoidance, distress tolerance, and everyday participation help clarify the meaning of maintained gains.
Bandelow (2018) synthesized follow-up studies of psychological treatments for panic disorder, generalized anxiety disorder, and social anxiety disorder. The review found that psychotherapy gains were generally maintained across follow-up intervals up to two years but also emphasized important interpretive limits: medication and some placebo conditions showed durability, spontaneous remission may contribute, and pre-post follow-up change does not itself prove a specific enduring treatment mechanism. Different anxiety conditions and outcome instruments further complicate aggregation.
Anxiety maintenance research should ask whether treatment fosters flexible approach behavior, whether learning persists across life transitions, and which reminders or new stressors prompt a return to safety behaviors. It should test the added value of booster exposure, context variation, and follow-up contacts against plausible controls. The available evidence establishes that enduring outcomes are possible, while the strongest inference about an added prevention component still depends on randomized, adequately powered, condition-specific comparisons.
Exposure Therapy, Inhibitory Learning, and Return of Fear
Exposure-based treatments provide a well-developed mechanistic framework for durability. Extinction learning is often understood as acquiring new inhibitory associations that compete with previously learned threat associations. Return of fear may occur through changes in context, renewed aversive experience, or passage of time. These laboratory phenomena are informative models for persistent avoidance and threat responses, although the transfer from conditioning experiments to clinical outcomes requires direct empirical validation.
Craske (2014) outlined strategies intended to strengthen inhibitory learning, including expectancy violation, variable practice, multiple contexts, and reduced reliance on safety signals. Their framework subsequently evolved toward an inhibitory retrieval emphasis in Craske (2022). These are substantive theories that organize therapeutic practice and research, rather than proof that every proposed technique has an independently demonstrated relapse-prevention effect in every anxiety disorder.
Experimental evidence provides narrower tests. Wang (2024) synthesized human fear-conditioning renewal paradigms and reported that context variation altered renewal effects. Such findings encourage interventions that test learning in more than one setting and evaluate retrieval when circumstances change. Yet a decline in conditioned responses during laboratory tests is not equivalent to preventing clinically diagnosed recurrence over years. Maintenance research should therefore connect laboratory mechanism measures to behavioral avoidance, symptom events, and functioning through longitudinal clinical studies.
Obsessive-Compulsive Disorder and the Maintenance of Response Prevention
For obsessive-compulsive disorder, exposure and response prevention aims to alter the relationship between intrusive experiences, distress, ritualizing, and avoidance. Maintenance involves continued capacity to encounter intrusive thoughts or relevant triggers without reinstating disabling compulsions and associated safety behaviors. Since obsessions can fluctuate and an individual may encounter new themes, sustained improvement often depends on generalization of response-prevention principles rather than memorized exposure hierarchies alone.
Hiss (1994) compared a relapse-prevention program with an attention-control intervention after intensive behavioral treatment in a sample of eighteen participants. At six months, the prevention group remained improved whereas the control group showed some symptom return. The design supports further investigation but the very small sample limits confidence in precise effect estimates. McKay (1997) reported on a two-year maintenance program after exposure and response prevention, describing sustained improvements on several obsessive-compulsive measures. This follow-up does not substitute for a large randomized test of individual program components.
Scientific evaluation should distinguish normal intrusive thoughts, transient ritual urges, a limited lapse in response prevention, and clinically significant deterioration. Changes in family accommodation, new stress, co-occurring depression, and access to specialist treatment can alter long-term outcomes. For a maintenance mechanism to be established, investigators must demonstrate that sustained use of response-prevention skills or targeted follow-up predicts or causes improvement beyond initial treatment response and relevant confounders.
Severe Emotion Dysregulation, Self-Harm, and Skills Continuity
In treatments addressing chronic emotional dysregulation and recurrent self-injurious behavior, maintenance can involve sustaining safer behavioral responses during periods of intense distress. Dialectical behavior therapy offers a useful example because it explicitly teaches mindfulness, distress-tolerance, emotion-regulation, and interpersonal skills while targeting dangerous behavior through structured clinical care. These skills may need to be available rapidly and under conditions that challenge attention and problem solving. The scientific outcome is the patient's subsequent safety and functioning, not simply whether a skills worksheet continues to be completed.
In a randomized trial with a year of treatment and a further year of follow-up, Linehan (2006) compared dialectical behavior therapy with community treatment by experts among 101 women with recent suicidal or self-injurious behavior and borderline personality disorder. Results favored dialectical behavior therapy on several important outcomes across treatment and follow-up. Interpretation requires the trial's particular eligibility criteria, treatment contrast, assessment intervals, and historical clinical setting. It does not establish that a single coping exercise prevents future self-harm in broader populations.
Maintenance in this domain is inseparable from clinical risk assessment and accessible services. A return of suicidal behavior, medical instability, or severe functional deterioration demands appropriate professional response rather than classification as an ordinary skills lapse. Research should test how independent skill access, crisis planning, therapeutic continuity, and social resources relate to safe outcomes, using methods that protect participants and do not compromise urgent care.
Bipolar Disorders, Psychoeducation, and Interpersonal Supports
Psychosocial maintenance in bipolar disorders is usually studied as an adjunct to clinically indicated medical treatment, with a focus on understanding illness patterns, sleep and daily rhythms, recognition of emerging mood episodes, problem solving, and collaborative response with family or caregivers where appropriate. The relevant preventive events include depressive and manic or hypomanic episodes, hospitalization, disruption of functioning, and treatment discontinuity. These outcomes differ in severity and consequences, making it important to report the polarity and definition of recurrence.
Colom (2003) randomized euthymic people with bipolar disorders to a group psychoeducation intervention or a comparison condition, contributing important evidence for relapse-focused psychosocial care. A later Colom (2009) examined longer-term outcomes. Separately, Miklowitz (2003) studied family-focused psychoeducation alongside pharmacotherapy. These investigations support serious consideration of structured psychosocial approaches, while comparative conclusions must remain tied to treatment exposure, existing medical care, episode history, and trial methods.
The psychological mechanisms proposed include better recognition of early changes, greater communication about support needs, reduced family conflict, and more effective organization of everyday routines. Their individual contributions require mediation and dismantling research. Psychoeducation is not a substitute for medical evaluation, and any maintenance account must preserve the distinctions between patient learning, adherence to prescribed treatment, medication effects, and the natural variability of illness.
Psychosis and Family-Based Prevention of Deterioration
For schizophrenia-spectrum disorders, maintenance research examines relapse, hospitalization, symptom worsening, social participation, and the burden of treatment. Psychosocial interventions often add to ongoing medical and community services, meaning that their effectiveness is conditioned by the wider care pathway. Family interventions may combine information, communication strategies, collaborative problem solving, and support for navigating service transitions. Their preventive outcomes therefore involve both patient-level processes and the organization of interpersonal and institutional care.
Bighelli (2021) conducted a systematic review and network meta-analysis of psychosocial and psychological interventions for relapse prevention in schizophrenia. The synthesis compared randomized trials of multiple approaches, usually added to antipsychotic treatment. It found evidence of relapse reduction for family interventions, structured prevention programs, cognitive behavioral therapy, and several forms of psychoeducation, while the confidence in specific estimates ranged from moderate to very low. Network comparisons depend on assumptions about the comparability of participants, intervention settings, and trial controls.
The maintenance question here is not whether a person has permanently acquired a generic mental-health skill. It is whether an intervention changes the probability and consequences of deterioration within a chronic care system. A rigorous account includes adverse outcomes, patient preferences, medication treatment, social inequality, family burden, and access to suitable services. Individualized care decisions require clinicians with relevant expertise; the research evidence informs population-level comparisons rather than replacing professional assessment.
Substance Use and Behavioral Relapse-Prevention Traditions
Relapse-prevention research in substance-use disorders developed detailed accounts of high-risk situations, craving, coping responses, and the progression from initial substance use to sustained problematic use. Psychological maintenance may involve practicing coping responses, identifying triggering contexts, changing environmental access, building non-using routines, and maintaining supportive relationships. The term relapse is operationalized differently across studies: any substance use, heavy-use episodes, days of use, and diagnostic impairment are distinct outcomes. A one-time event is especially difficult to interpret without assessing the circumstances and consequences of that event.
In a randomized aftercare trial, Bowen (2014) compared mindfulness-based relapse prevention, cognitive-behavioral relapse prevention, and treatment as usual among 286 adults who had completed initial substance-use treatment. The study reported advantages for both structured prevention conditions over usual care on some outcomes at six months, and distinctive longer-term patterns by twelve months. It provides an empirical comparison of ongoing behavioral strategies, but its results remain specific to the aftercare setting, participant characteristics, and outcome definitions.
Witkiewitz (2010) examined associations among depressive symptoms, craving, and use following mindfulness-based relapse prevention, suggesting possible changes in the way negative affect relates to craving. Their analyses help specify mediating hypotheses rather than proving all proposed components causal. Relapse-prevention findings for substance use cannot simply be translated into evidence about anxiety relapse or depression recurrence. Substance-specific biological consequences, withdrawal effects, overdose risk, and clinical or harm-reduction services require their own expert evidence and policy context.
Early-Warning Signs, Self-Monitoring, and Action Thresholds
Monitoring can support maintenance if it generates timely, interpretable information and leads to an effective response. Relevant indicators may include symptom intensity, behavioral avoidance, sleep pattern, mood variability, craving, concentration, daily participation, and interpersonal strain. Some are nonspecific and occur commonly without relapse. A warning sign therefore has predictive value only to the extent that a defined pattern improves discrimination between likely deterioration and ordinary fluctuation. Repeated measurement should be evaluated for both sensitivity and the burden of false alarms.
The National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations (2022) recommends identifying early changes, stressful situations, and recognizable unhelpful behaviors and formulating contingent responses. Such guidance supports collaborative monitoring, but there is substantial distance between a sensible clinical practice and a validated personalized prediction tool. False-positive alerts may heighten vigilance or anxiety; false negatives may delay access to care. Outcomes should include the consequences of acting on monitoring signals as well as predictive accuracy.
A monitoring plan is strongest when it defines the indicator, observation period, likely interpretation, available support, and appropriate action in language the person can understand. Researchers should prospectively assess whether individuals actually use the plan, whether thresholds remain stable across different phases of life, and whether monitoring improves patient-important outcomes. A system that predicts fluctuations yet does not improve care or functioning has limited preventive value.
Relapse-Response Planning and Contingency Design
A relapse-response plan translates learning into conditional action: if a recognizable pattern emerges, specific coping, support, and service steps become available. Its scientific value comes from bridging the interval between noticing deterioration and implementing an appropriate response. Plans can include renewed behavioral practice, contact with a professional, adjustment of environmental demands, collaborative discussion, or reconsideration of treatment goals. They should be tailored to the condition, consequences of deterioration, and personal resources.
The contents of an effective plan cannot be inferred from generic lists of warning signs. The plan must be executable under distress and should account for reduced concentration, avoidance, shame, or competing obligations. A strategy that requires extensive self-monitoring or perfect recall at a crisis point may be less useful than a clear, rehearsed route to help. Plan quality can be studied through behaviorally defined implementation, independent assessment of appropriateness, and follow-up of event severity and duration.
The National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations (2022) exemplify collaborative planning after treatment for depression. However, rigorous component research remains necessary to determine whether an individualized plan adds benefits to the other active ingredients of psychotherapy or routine care. Interventions should report their target population, expected mechanism, dose, preparation requirements, follow-up accessibility, and any unintended consequences.
Booster Sessions and the Dose of Continued Contact
Booster sessions are intermittent therapeutic contacts intended to revisit skills, address new circumstances, or strengthen previously achieved changes after an intensive treatment course. Their timing may be fixed, risk-responsive, requested by the patient, or attached to a transition. Scientific evaluation has to separate the benefits of additional therapeutic attention from benefits attributable to specific skills or methods. An apparently favorable outcome among people who voluntarily attend boosters may reflect their motivation, access to care, or lower clinical severity.
The continuation cognitive-therapy trial by Jarrett (2001) provides direct evidence about a defined extension of treatment among higher-risk depression responders. Bockting (2005) examined a brief preventive group course after remission. These trials should not be described as proving that every short check-in or universally scheduled booster session is equally effective. Their interventions, populations, control conditions, and durations are substantially different.
The research design needed for booster optimization includes randomization of timing and dose after a defined response, preferably with clearly specified comparator contact. Outcomes should encompass symptom trajectories, relapse events, participation, therapeutic burden, cost, and equity of access. Such work could identify when further support is advantageous and when patients can confidently sustain gains without continued scheduled therapy. The appropriate amount of contact is a testable treatment-policy question rather than a fixed property of psychotherapy.
Mindfulness, Metacognitive Awareness, and Flexible Responding
Several preventive treatments aim to change how patients react to thoughts, feelings, bodily sensations, and early symptoms. Mindfulness-based cognitive therapy has a strong depression-specific research tradition; mindfulness-based relapse prevention extends related practices to substance-use aftercare. Both emphasize noticing experiences and selecting responses rather than automatically engaging in familiar cognitive or behavioral cycles. Their common conceptual language should not obscure differences in study population, treatment curriculum, and outcome.
Teasdale (2000) investigated a prevention intervention for recurrent depression; Bowen (2014) compared relapse-prevention strategies after substance-use treatment. Neither finding justifies the proposition that mindfulness as an isolated ingredient guarantees durable outcomes across diagnostic categories. Mediating variables may include attentional flexibility, decentering, reduced perseverative thinking, or altered response to craving, and these require validated measures and temporally ordered data.
Maintenance research should also consider the feasibility of continuing formal practice after treatment. People vary in time, privacy, cultural fit, accessibility, and prior experiences with contemplative practices. A prevention program becomes more scientifically interpretable when it measures what is actually practiced, whether practice is associated with outcomes independently of selection, and whether plausible alternatives produce similar effects. Mechanism claims require stronger evidence than descriptive correlations among practice frequency and later symptom levels.
Treatment Engagement, Planned Completion, and Unplanned Dropout
Maintaining gains after planned completion differs from evaluating outcomes after treatment stops prematurely. People discontinue care for many reasons: satisfactory improvement, competing demands, dissatisfaction, side effects, mismatched expectations, poor alliance, financial limitations, transportation barriers, and worsening symptoms. A research dataset containing only treatment completers cannot represent the full population starting psychotherapy. It may especially underrepresent people whose conditions or circumstances made consistent attendance difficult.
A maintenance trial enrolling responders selects a clinically meaningful group but cannot answer whether the entire original treatment pathway leads to durable success for all starters. Investigators should report recruitment, randomization, initial response, subsequent attrition, additional care, and the analytic population at each stage. Intention-to-treat estimates can protect randomized comparisons, while missing-data assumptions still matter. The resulting distinctions are central to truthful claims about effectiveness in everyday services.
Clinical planning may include a negotiated route for returning to therapy when new difficulties arise. Such arrangements are part of continuity of care and can also be studied as interventions. Their quality depends on clear service availability and shared expectations, not on indefinite therapeutic dependence. Maintenance research should distinguish access to optional follow-up from compulsory attendance and assess patients' experiences of autonomy, confidentiality, and sustained functioning.
Lifespan, Developmental Transitions, and Age-Specific Maintenance
A therapeutic skill learned at one developmental stage may encounter different demands at another. Children often depend upon caregivers and school environments to sustain changes. Adolescents undergo rapid shifts in autonomy, identity, peer relationships, and daily contexts. Adults may face family formation, caregiving, employment transitions, and chronic medical conditions. Older adults may experience bereavement, mobility constraints, changes in social networks, or sensory and cognitive limitations. These differences affect what maintenance means and how it can be measured.
Evidence from adult depression trials should not be generalized automatically to youth or older populations. Age can modify access to intervention resources, the meaning of a recurrence, reliable measurement, and the role of family. Even when a common therapeutic technique is used across ages, the support structure and target outcomes can differ. A developmentally appropriate maintenance evaluation should distinguish symptom improvement from adaptive participation in the settings relevant to the age group.
Longitudinal studies that span major developmental changes can reveal whether therapeutic competencies transfer across contexts or require renewed guidance. Investigators need repeated assessment of life events, caregiving arrangements, new treatments, and changes in diagnostic presentation. Maintenance is then understood as the capacity for ongoing adaptation rather than preservation of an unchanging state. This perspective encourages preventive strategies to be responsive to transitions while keeping clinical claims grounded in population-specific evidence.
Culture, Equity, and the Conditions for Lasting Improvement
Psychotherapy research commonly draws from specific health systems, languages, diagnostic frameworks, and recruitment channels. The durability of gains in a well-resourced research clinic may differ from outcomes in communities facing unstable access to care, displacement, stigma, poverty, or limited specialist availability. Cultural meanings of recovery also vary across relationships, social roles, and understandings of distress. Measurement instruments and follow-up procedures require attention to whether they capture comparable constructs across populations.
Maintenance interventions can impose hidden resource demands: time off work, reliable internet, private space, transportation, caregiver support, and the ability to pay for additional sessions. These demands should be recorded as implementation variables and potential effect modifiers. An intervention that is efficacious under intensive trial conditions may have limited reach or sustainment in ordinary settings. Studies should report who was excluded, who was lost during follow-up, and whether the available evidence applies to the population being discussed.
Equity-focused research evaluates sustained functioning, access to timely help, treatment burden, and adverse experiences as well as symptom recurrence. It can compare flexible delivery, culturally adapted materials, and community-linked support while specifying what has been tested. A universal relapse-prevention narrative is scientifically weaker than one that shows how clinical effects depend on baseline vulnerability, opportunity to practice, and a functioning care environment.
Comorbidity, Chronic Stress, and Physical Health
Psychological difficulties rarely unfold in isolation. Depression may coexist with anxiety, chronic pain, sleep disturbance, substance-use problems, or medical illness. The target symptoms can improve while other pressures persist, and those remaining pressures may alter the trajectory after treatment. Persistent adversity or physical illness can also make exercise, social engagement, work participation, and clinical follow-up more difficult. Maintenance research should therefore distinguish the disorder treated from the broader conditions affecting its long-term expression.
The prospective depression work of Judd (1998) illustrates the prognostic importance of residual symptoms, while the National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations (2022) includes physical and mental health comorbidity and unresolved environmental stressors among considerations for relapse risk. Such evidence does not imply that all contextual risk is modifiable by psychotherapy alone. Some threats require medical care, housing assistance, social support, or other coordinated services.
An adequate study measures these influences at several time points instead of treating them all as fixed baseline covariates. Changing sleep, medication, employment, social roles, and care use may both influence symptoms and be influenced by them. Analyses of mediators and time-varying confounding must be designed accordingly. The resulting picture is more accurate than an account in which maintenance depends only on remembering a skill or completing a fixed set of exercises.
Digital Aftercare and Technology-Assisted Maintenance
Digital tools can provide reminders, structured practice, self-monitoring, brief psychoeducational material, or communication with clinical services after face-to-face treatment ends. Their main proposed advantages are reach, flexible timing, and repeated access to learned materials. Their limitations include engagement decay, unequal device and connectivity access, privacy concerns, mistaken alerts, and difficulty interpreting symptoms without adequate clinical context. A digital intervention can be convenient without having demonstrated a reduction in clinically defined relapse.
Petre (2024) systematically reviewed internet- and mobile-based aftercare and relapse-prevention interventions for anxiety and depressive disorders. The evidence was more extensive for depression than anxiety; studies measuring relapse and recurrence showed mixed findings, and methodological quality and engagement varied. This is a useful warning against assuming that improved symptom scores or frequent app use prove durable prevention. A digital program requires an explicit comparator, longitudinal outcome definitions, and evidence that the supported activities contribute to patient-important results.
Digital aftercare must specify responsibility when risk indicators appear. The privacy and consent implications of repeated mental-health monitoring are especially important if data are stored, shared, or used by third-party systems. Researchers should document false alarms, data discontinuity, and differential exclusion. In practical services, technology can be investigated as an adjunct to accessible human care, with clear boundaries around what monitoring does and what it cannot establish.
Human–Artificial Relations and the Future of Maintenance Research
The Artificial Era introduces a new class of environments in which psychological support, memory aids, reflective conversations, and behavioral prompts may be mediated by artificial systems. Such systems can help organize a person's plans, retrieve previously learned material, or make patterns across repeated observations easier to inspect. These are operationally definable functions. They create research opportunities in cognitive offloading, prospective memory, interaction design, and long-term human–artificial coordination, especially when a person is managing learned therapeutic skills outside the clinic.
Scientific testing requires precise differentiation of functions and claims. An artificial conversational system may supply reminders, summarize user-entered observations, or support a structured reflection task; each function has different possible effects and safety requirements. Evidence that a reminder was delivered is not evidence that a psychological gain was maintained. Evidence of user satisfaction is not evidence of reduced relapse incidence. A clinical trial would need prospective allocation, validated outcomes, adequate follow-up, protected data, explicit human clinical oversight, and assessment of harms such as overreliance or delayed access to professional treatment.
Psychology by Bogdanova situates this prospective research within the wider horizon Artificial Era · From Homo to Artificial. The philosophical framework supplies questions about the organization of agency and knowledge; the empirical research must independently establish what a specific system does and what outcome changes follow. This separation preserves the value of conceptual inquiry while preventing theoretical vocabulary from being mistaken for demonstrated therapeutic efficacy.
Implementation Science and the Continuity of Care
A maintenance method that works under research conditions may fail during routine implementation if the necessary staff, follow-up appointments, training, or referral pathways are absent. Implementation science asks whether the intervention reaches its intended population, is delivered with sufficient fidelity, fits local resources, and can be sustained beyond an initial project. Psychotherapy maintenance often spans multiple services and years, so continuity and coordination are part of the intervention environment.
The National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations (2022) provides a concrete example of how relapse-prevention principles can be incorporated into a care pathway through shared decisions, structured psychological interventions, and review of ongoing risk. The existence of such recommendations does not demonstrate universal uptake or equivalent outcomes across health systems. Local audits should examine appointment availability, clinical documentation, referral completion, patient preferences, and outcomes after treatment has ended.
Implementation trials can compare proactive follow-up, stepped-care reentry, group maintenance, and digitally supported practice. They should state how intervention fidelity is measured and how usual care differs between sites. Sustainability is better established when both clinical effectiveness and actual service capacity are evaluated across time. The ultimate target is durable improvement for the treated population, including those whose circumstances make conventional follow-up difficult.
Critical Interpretation of Evidence and Competing Explanations
Maintenance studies are vulnerable to explanations that can mimic intervention effects. Participants who complete treatment may already have better prognosis than those who leave. Regression to the mean and spontaneous improvement can make follow-up outcomes appear favorable. Additional treatment obtained after randomization can alter observed differences. Different relapse thresholds can produce very different event rates from the same underlying symptom trajectory. Unblinded assessment, selective reporting, publication bias, and incomplete follow-up can further distort conclusions.
Competing causal mechanisms also need direct evaluation. A preventive course might help through skill acquisition, therapist contact, expectancy, renewed symptom treatment, improved adherence to existing medical care, or changes in social support. Randomization to an entire program estimates the combined effect of assignment but does not identify the contribution of each mechanism. To establish a component's causal role, investigators need appropriate dismantling, factorial, mediation, or sequential designs and explicit timing of variables.
The follow-up meta-analysis by Bandelow (2018) explicitly cautioned that durable improvement after anxiety treatment may be influenced by spontaneous remission or regression to the mean. The partial-remission synthesis by Gülpen (2025) illustrates how individual participant data can sharpen estimates in a defined subpopulation while preserving residual uncertainty. The scientific synthesis is strongest when it reports where evidence is direct, where it is indirect, and what specific comparison remains unresolved.
A Research Agenda for Sustainable Therapeutic Change
The strongest next generation of maintenance studies will combine precise event definitions with rich descriptions of what was learned during treatment. Randomized trials should test booster timing, skill rehearsal, follow-up accessibility, preventive intervention components, and individualized support algorithms against well-defined alternatives. Repeated ecological assessment can clarify whether symptom changes follow lapses in practice, environmental challenges, biological stressors, or combinations of these influences. Where appropriate, researchers should integrate functional outcomes, quality of life, treatment burden, and patient-defined goals.
Mechanism studies need to measure proposed processes before outcome changes and account for time-varying confounding. A trial that claims mindfulness prevents relapse through decentering, or exposure prevents recurrence through inhibitory retrieval, should measure the relevant construct independently and test alternative pathways. Longitudinal work must also include people who do not complete the acute intervention, and it should report recruitment, attrition, new treatment, and adverse events. Comparative evidence should be distributed across ages, cultures, service settings, and levels of clinical complexity rather than concentrated in one highly selected research population.
The most promising interdisciplinary program integrates psychological treatment science, longitudinal statistics, implementation science, and ethically designed digital support. It treats maintenance as a dynamic problem: learned strategies operate in changing lives. The empirical task is to discover which combinations of patient competence, contextual opportunity, timely monitoring, and accessible care most reliably sustain meaningful improvement for identifiable groups over specified periods.
Conclusion
Maintenance of therapeutic gains is a distinct subject within psychological treatment science. It concerns the durability, generalization, and renewal of changes achieved during therapy, together with the strategies intended to reduce later clinical deterioration. The evidence base contains randomized continuation cognitive-therapy trials, preventive cognitive interventions after depression remission, mindfulness-based programs, relapse-prevention components in exposure-based care, and psychosocial family and addiction aftercare interventions. These research traditions demonstrate that maintenance can be studied experimentally and that the benefits of some additional strategies extend beyond the immediate treatment period.
The scientific evidence also establishes essential distinctions. A preserved symptom score is different from an independently demonstrated therapeutic skill; an enduring outcome is different from proof that one component caused it; a brief setback is different from a clinically defined recurrence. The generalizability of maintenance findings depends on diagnosis, prior treatment response, comparator, episode definition, follow-up duration, environmental constraints, and new treatment exposure. Both patient competence and the circumstances supporting its use deserve prospective measurement.
The central synthesis is that durable psychological improvement is an achievement across time, settings, and changing conditions. The next research frontier is to identify experimentally which forms of continued support, independent practice, preventive training, and service continuity yield meaningful benefits, for whom, and with what burden or risks. Such knowledge can make relapse prevention a more precise, humane, and accountable field of psychological intervention research.
References
- Bandelow, B., Sagebiel, A., Belz, M., Görlich, Y., Michaelis, S., & Wedekind, D. (2018). Enduring effects of psychological treatments for anxiety disorders: Meta-analysis of follow-up studies. British Journal of Psychiatry, 212(6), 333–338. https://doi.org/10.1192/bjp.2018.49
- Bighelli, I., Rodolico, A., García-Mieres, H., Pitschel-Walz, G., Hansen, W.-P., Schneider-Thoma, J., Siafis, S., Wu, H., Wang, D., Salanti, G., Furukawa, T. A., Barbui, C., & Leucht, S. (2021). Psychosocial and psychological interventions for relapse prevention in schizophrenia: A systematic review and network meta-analysis. The Lancet Psychiatry, 8(11), 969–980. https://doi.org/10.1016/S2215-0366(21)00243-1
- Bockting, C. L. H., Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005). Preventing relapse/recurrence in recurrent depression with cognitive therapy: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 73(4), 647–657. https://doi.org/10.1037/0022-006X.73.4.647
- Bockting, C. L. H., Spinhoven, P., Wouters, L. F., Koeter, M. W. J., & Schene, A. H. (2009). Long-term effects of preventive cognitive therapy in recurrent depression: A 5.5-year follow-up study. Journal of Clinical Psychiatry, 70(12), 1621–1628. https://doi.org/10.4088/JCP.08m04784blu
- Bockting, C. L. H., Klein, N. S., Elgersma, H. J., van Rijsbergen, G. D., Slofstra, C., Ormel, J., Buskens, E., Dekker, J., de Jong, P. J., Nolen, W. A., Schene, A. H., Hollon, S. D., & Burger, H. (2018). Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): A three-group, multicentre, randomised controlled trial. The Lancet Psychiatry, 5(5), 401–410. https://doi.org/10.1016/S2215-0366(18)30100-7
- Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., Hsu, S. H., Carroll, H. A., Harrop, E., Collins, S. E., Lustyk, M. K., & Larimer, M. E. (2014). Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial. JAMA Psychiatry, 71(5), 547–556. https://doi.org/10.1001/jamapsychiatry.2013.4546
- Breedvelt, J. J. F., Warren, F. C., Segal, Z., Kuyken, W., & Bockting, C. L. H. (2021). Continuation of antidepressants vs sequential psychological interventions to prevent relapse in depression: An individual participant data meta-analysis. JAMA Psychiatry, 78(8), 868–875. https://doi.org/10.1001/jamapsychiatry.2021.0823
- Colom, F., Vieta, E., Martínez-Arán, A., Reinares, M., Goikolea, J. M., Benabarre, A., Torrent, C., Comes, M., Corbella, B., Parramon, G., & Corominas, J. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60(4), 402–407. https://doi.org/10.1001/archpsyc.60.4.402
- Colom, F., Vieta, E., Sánchez-Moreno, J., Palomino-Otiniano, R., Reinares, M., Goikolea, J. M., Benabarre, A., & Martínez-Arán, A. (2009). Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. British Journal of Psychiatry, 194(3), 260–265. https://doi.org/10.1192/bjp.bp.107.040485
- Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014). Maximizing exposure therapy: An inhibitory learning approach. Behaviour Research and Therapy, 58, 10–23. https://doi.org/10.1016/j.brat.2014.04.006
- Craske, M. G., Treanor, M., Zbozinek, T. D., & Vervliet, B. (2022). Optimizing exposure therapy with an inhibitory retrieval approach and the OptEx Nexus. Behaviour Research and Therapy, 152, 104069. https://doi.org/10.1016/j.brat.2022.104069
- Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., Rush, A. J., & Weissman, M. M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48(9), 851–855. https://doi.org/10.1001/archpsyc.1991.01810330075011
- Gortner, E. T., Gollan, J. K., Dobson, K. S., & Jacobson, N. S. (1998). Cognitive-behavioral treatment for depression: Relapse prevention. Journal of Consulting and Clinical Psychology, 66(2), 377–384. https://doi.org/10.1037/0022-006X.66.2.377
- Gülpen, J., Breedvelt, J. J. F., van Dis, E. A. M., Geurtsen, G. J., Warren, F. C., van Heeringen, C., Hitchcock, C., Holländare, F., Huijbers, M. J., Jarrett, R. B., Jermann, F., de Jonge, M., Klein, D. N., Klein, N. S., Ma, S. H., Moore, M. T., Denys, D. A. J. P., Williams, J. M. G., Kuyken, W., & Bockting, C. L. H. (2025). Psychological interventions for preventing relapse in individuals with partial remission of depression: A systematic review and individual participant data meta-analysis. Psychological Medicine, 55, e50. https://doi.org/10.1017/S0033291725000157
- Hiss, H., Foa, E. B., & Kozak, M. J. (1994). Relapse prevention program for treatment of obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 62(4), 801–808. https://doi.org/10.1037/0022-006X.62.4.801
- Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O'Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., & Gallop, R. (2005). Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry, 62(4), 417–422. https://doi.org/10.1001/archpsyc.62.4.417
- Jarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G. G., & Silver, P. C. (2001). Preventing recurrent depression using cognitive therapy with and without a continuation phase: A randomized clinical trial. Archives of General Psychiatry, 58(4), 381–388. https://doi.org/10.1001/archpsyc.58.4.381
- Jarrett, R. B., Minhajuddin, A., Gershenfeld, H., Friedman, E. S., & Thase, M. E. (2013). Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: A randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry, 70(11), 1152–1160. https://doi.org/10.1001/jamapsychiatry.2013.1969
- Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., Rice, J. A., & Keller, M. B. (1998). Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders, 50(2–3), 97–108. https://doi.org/10.1016/S0165-0327(98)00138-4
- Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., Lewis, G., Watkins, E., Brejcha, C., Cardy, J., Causley, A., Cowderoy, S., Evans, A., Gradinger, F., Kaur, S., Lanham, P., Morant, N., Richards, J., Shah, P., … Byford, S. (2015). Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): A randomised controlled trial. The Lancet, 386(9988), 63–73. https://doi.org/10.1016/S0140-6736(14)62222-4
- Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., Huijbers, M., Ma, H., Schweizer, S., Segal, Z., Speckens, A., Teasdale, J. D., Van Heeringen, K., Williams, M., Byford, S., Byng, R., & Dalgleish, T. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: An individual patient data meta-analysis from randomized trials. JAMA Psychiatry, 73(6), 565–574. https://doi.org/10.1001/jamapsychiatry.2016.0076
- Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63(7), 757–766. https://doi.org/10.1001/archpsyc.63.7.757
- McKay, D. (1997). A maintenance program for obsessive-compulsive disorder using exposure with response prevention: 2-year follow-up. Behaviour Research and Therapy, 35(4), 367–369. https://doi.org/10.1016/S0005-7967(96)00105-2
- Miklowitz, D. J., George, E. L., Richards, J. A., Simoneau, T. L., & Suddath, R. L. (2003). A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Archives of General Psychiatry, 60(9), 904–912. https://doi.org/10.1001/archpsyc.60.9.904
- National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
- Petre, L. M., Piepiora, P. A., Gemescu, M., & Gheorghe, D. A. (2024). Internet- and mobile-based aftercare and relapse prevention interventions for anxiety and depressive disorders: A systematic review. Frontiers in Psychology, 15, 1474016. https://doi.org/10.3389/fpsyg.2024.1474016
- Strunk, D. R., DeRubeis, R. J., Chiu, A. W., & Alvarez, J. (2007). Patients' competence in and performance of cognitive therapy skills: Relation to the reduction of relapse risk following treatment for depression. Journal of Consulting and Clinical Psychology, 75(4), 523–530. https://doi.org/10.1037/0022-006X.75.4.523
- Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68(4), 615–623. https://doi.org/10.1037/0022-006X.68.4.615
- Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007). Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy's effects. Journal of Consulting and Clinical Psychology, 75(3), 475–488. https://doi.org/10.1037/0022-006X.75.3.475
- Wang, Y., Olsson, S., Lipp, O. V., & Ney, L. J. (2024). Renewal in human fear conditioning: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 159, 105606. https://doi.org/10.1016/j.neubiorev.2024.105606
- Witkiewitz, K., & Bowen, S. (2010). Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. Journal of Consulting and Clinical Psychology, 78(3), 362–374. https://doi.org/10.1037/a0019172
Social Relationships, Family Participation, and Environmental Reinforcement
Psychotherapeutic gains are maintained within interpersonal settings. Family members, intimate partners, peers, supervisors, and community institutions may respond to changed behavior in ways that reinforce or obstruct new patterns. A person can acquire greater assertiveness in therapy yet face coercive dynamics at home or work. A successful approach to anxiety may be discouraged by repeated reassurance or accommodation from well-intentioned relatives. Social isolation, prejudice, discrimination, and economic insecurity can change the opportunities available for maintaining learned skills.
The bipolar and psychosis literatures contain experimental investigations of family-oriented prevention. Miklowitz (2003) compared family-focused psychoeducation alongside pharmacotherapy with a control condition in bipolar disorder. Bighelli (2021) synthesized psychosocial strategies in schizophrenia, including family approaches. These results support the importance of interpersonal context while leaving mechanism-specific questions unresolved. Family involvement should remain collaborative, condition-specific, and respectful of patient preferences and safety.
An ecological maintenance model specifies opportunities to enact therapeutic behavior, incentives that support it, and threats that make it difficult. Research should measure both patient skills and relevant external conditions, including availability of community services and practical accommodations. Social support is a heterogeneous construct; the effects of trusted, autonomy-supporting assistance can differ markedly from controlling involvement or burdensome surveillance. Durable improvement is therefore best examined as an interaction between acquired capacities and the conditions under which they are exercised.